More on how Merck may prevail after all:
On the other hand, attorney Ted Mayer, a partner at Hughes, Hubbard and Reed in New York, provides some numbers of his own, specifically how only four of the 20 cases against Merck, the manufacturer of Vioxx, scheduled to be brought to trial have resulted in a plaintiffs verdict.“I don’t know. I think it might surprise people,” said Mayer, part of Merck’s defense team. “It will surprise people who think they can file a case and magically good things will happen. Lawyers out there should take a hard look at it.”
(via PointofLaw.com)
Related posts:
- A jury of "uneducated casino workers" beat the hell out of Merck
- Merck’s prevailing Vioxx strategy
- Medical journals and trolling for potential plaintiffs
- Losing a $14M malpractice verdict
- "The trial lawyer lobby is strong, but ultimately they in are in-the-wrong"
- Sore loser
- Promoting medication adherence via lottery
KevinMD.com on Facebook
Comments on this entry are closed.